Disposable Biopharmaceutical Processes–Myth or Reality? - - BioPharm International

ADVERTISEMENT

Disposable Biopharmaceutical Processes–Myth or Reality?


BioPharm International


Keith DiBlasi is the manager of technical services, Sartorius North America, Inc., Edgewood, NY. Maik W. Jornitz is the group vice president of bioprocess biosystems. Uwe Gottschalk, PhD, is the group vice president of purification technologies, Sartorius AG, Goettingen, Germany. Paul M. Priebe is head of product management process, Edgewood, NY.

References

1. Sinclair A, Monge M. Quantitative economic evaluation of single use disposables in bioprocessing. Pharmaceutical Eng. 2002;22: 20–34.

2. Prashad M, Tarrach K. Depth filtration aspects for the clarification of CHO cell derived biopharmaceutical feed streams. FISE. 2006;9:28–30.

3. Mora J, Sinclair A, Delmdahl N, Gottschalk U. Disposable membrane chromatography: performance analysis and economic cost model. BioProcess Int. 2006;4:38–43.

4. Zhou JX, Tressel T. Membrane chromatography as a robust purification system for large scale antibody production. BioProcess Int.2005; 3: 32–37.

5. Zhou JX, Tressel T. Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol Progr. 2006;22:341–9.

6. Ransohoff T. Disposable Chromatography: Current Capabilities and Future Possibilities. BPD North Carolina Biotechnology Center, 2004 Nov 18.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Supports Restricted Access Bill
September 18, 2014
Baxter Initiates Voluntary Recall of Potassium Chloride Injection
September 17, 2014
European Commission Approves RoACTEMRA for Treatment of RA
September 9, 2014
PDA Announces Technical Report on Drug Shortages
September 9, 2014
Infinity and AbbVie Collaborate to Develop Oncology Drug
September 5, 2014
Author Guidelines
Source: BioPharm International,
Click here